Pure Global

Anti-Cardiolipin IgM (Maglumi Anti-Cardiolipin IgM ) - India CDSCO Medical Device Registration

Anti-Cardiolipin IgM (Maglumi Anti-Cardiolipin IgM ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000036_ec49f76842818d87491c60bd0188b222_ec301a0cd04a11141e774ad31afccfaf. This device is marketed under the brand name MAGLUMI® Tip. The license holder is SNIBE DIAGNOSTIC (India) Private Limited., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Anti-Cardiolipin IgM (Maglumi Anti-Cardiolipin IgM )
UID: IMP/IVD/2023/000036_ec49f76842818d87491c60bd0188b222_ec301a0cd04a11141e774ad31afccfaf

Brand Name

MAGLUMI® Tip

Device Class

Class B

Approving Authority

CDSCO

Product Information

The kit is an in vitro chemiluminescence immunoassay for the quantitative determination of Anti-Cardiolipin IgM (MAGLUMI® Tip) in human serum and plasma

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing